Skip to main content

Peer Review reports

From: Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports

Original Submission
10 Nov 2020 Submitted Original manuscript
12 Nov 2020 Reviewed Reviewer Report - Emmanouil Kapetanakis
28 Nov 2020 Reviewed Reviewer Report - Otabek Yangibaev
10 Dec 2020 Author responded Author comments - Rishu Takimoto
Resubmission - Version 2
10 Dec 2020 Submitted Manuscript version 2
Publishing
14 Dec 2020 Editorially accepted
8 Apr 2021 Article published 10.1186/s13256-020-02634-z

You can find further information about peer review here.

Back to article page
\